Search results
Scilex reaches settlement in patent lawsuit over Gloperba By Investing.com
Investing.com· 13 hours agoFederal Trade Commission and Department of Justice...District of Delaware issued a Consent Judgment...
Decoding Pfizer Inc (PFE): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 5 days agoStrengths highlight Pfizer's robust product portfolio and global market presence. Weaknesses underscore the challenges in revenue fluctuations and patent...
$242 Million Patent Lawsuit: Quandary Peak's Analysis Crucial in Jury's Verdict Against Microsoft
FOX 4 Kansas City· 2 days agoA jury delivered a $242M verdict on Friday, May 10, in favor of plaintiff IPA Technologies in a...
Health Care Roundup: Market Talk
The Wall Street Journal· 1 day agoCantor Fitzgerald analyst Eric Schmidt said in a research note last month that the cancer drug Jakafi has a 2029 patent expiration, which is seen as a...
Q1 2024 Harrow Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 44 minutes agoOne last item of note on IHEEZO, is that the US Patent and Trademark Office recently granted IHEEZO a new set of patent claims with an expiration ...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 7 days agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...
Exelixis Files Patent Complaint Against Cipla's Cancer Treatment
Market Watch· 4 days agoThe company said on Friday that it's seeking an order to make the effective date of any FDA approval of Cipla's abbreviated new drug application after the expiration of a ...
Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 6 days agoWhile these products have been successful, this dependence makes the company vulnerable to market...
Damien Conover and Rebecca Springer: ‘We Are in a Healthcare Consumerization Moment Right Now’
Morningstar· 11 hours agoDamien is director of healthcare research and director of equity strategy for Morningstar Research...
Merck stopped a clinical trial for its experimental skin cancer drug after a high rate of side...
Quartz· 2 days agoMerck announced Monday that it is pulling the plug on its phase 3 trial of an experimental...
